Assessing and reducing risk for colorectal cancer

Block23’s first genomic test is Colo-Prevent, a clinically validated screen test for colorectal cancer (CRC), a disease with the 2nd highest occurrence of cancer. Based on genomic tests conducted on over 42,000 colorectal cancer patients and linked to personal data and lifestyle habits, Colo-Prevent represents an accurate reading of risk and offers a guide for managing your health.

Take a personal data and lifestyle risk assessment

This tool calculates the potential risk of colorectal cancer over the next 5 years, 10 years, and the lifetime risk for people over 50 years of age. The questionnaire takes about 5 minutes to complete. Combined with the Block23 genomic test for measuring genetic risk factors, doctors and patients can better understand the personal risk of colorectal cancer.

GO TO RISK CALCULATOR

Take a test to know your genomic risk

In addition to your personal and lifestyle risk, your genome may increase or lower your risk. A DNA Saliva Specimen Kit is sent to each individual for genomic analysis. The Colo-Prevent risk score is determined following analysis of the individual’s DNA by an algorithm programmed into encrypted software generating a patient report of relative lifetime risk of developing CRC.

Download information

Apply for receiving the Colo-Prevent test